does tirzepatide cause naion Do their associations with nonarteritic anterior ischemic optic neuropathy and other adverse outcomes make these drugs more risky than beneficial? Risk of nonarteritic anterior ischemic

Each 1 mg increase in tirzepatide dosage was associated with an additional 0.45 cm reduction in waist circumference ( = -0.4487

However, some studies suggest tirzepatide may produce greater average weight loss because it targets two hormones involved in appetite regulation instead of one.

The simplest approach: stick with your injection day based on your home time zone for the first week of travel

Metabolic flexibility as an adaptation to energy resources and requirements in health and disease

With the anti-obesity pharmacotherapy landscape rapidly evolving, two investigational agents from Eli Lilly have recently demonstrated highly promising Phase 2 results: Retatrutide (LY3437943) and Eloralintide (LY3841136)